| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc (IRWD) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $7.13M | - | |
| VP | 658.0K | $2.47M | - | |
| Other | 500.5K | $1.88M | - | |
| Other | 416.6K | $1.56M | - | |
| Other | 350.4K | $1.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2017 | Gilbert Halley E | Chief Legal Officer | Sale+OE | 37,385 | $16.75 | $626,198.75 | -100% | |
| Jan 12, 2017 | Hecht Peter M | Chief Executive Officer | Sale+OE | 65,987 | $15.67 | $1,034,016.12 | -0.7% | |
| Dec 5, 2016 | Olanoff Lawrence S | Director | Sell | 3,200 | $15.68 | $50,176.00 | -10.9% | |
| Nov 11, 2016 | Gilbert Halley E | Chief Legal Officer | Sale+OE | 14,000 | $16.75 | $234,500.00 | -100% | |
| Sep 6, 2016 | Olanoff Lawrence S | Director | Sell | 3,200 | $13.72 | $43,904.00 | -9.8% | |
| Aug 19, 2016 | Consylman Gina | Chief Accounting Officer | Sell | 207 | $13.54 | $2,802.78 | -1.0% | |
| Jun 3, 2016 | Olanoff Lawrence S | Director | Sell | 2,200 | $12.92 | $28,424.00 | -6.3% | |
| May 25, 2016 | Gilbert Halley E | Chief Legal Officer | Sale+OE | 20,275 | $12.19 | $247,152.25 | -23.9% | |
| Mar 11, 2016 | Hecht Peter M | Chief Executive Officer | Sale+OE | 120,000 | $10.72 | $1,286,400.00 | -0.8% | |
| Mar 9, 2016 | Currie Mark G53 | Chief Scientific Officer | Sale+OE | 150,000 | $10.86 | $1,629,000.00 | -28.6% |